References
- Todoriko LD, Petrenko VI, Denysov OS, Semіaniv IO, Sprynsіan TA, Pidverbetska OV. Severe cases of tuberculosis and substantiation of ways to influence the increase of treatment efficacy according to standard schemes. Tuberculosis, Lung Diseases, HIV-Infection. 2018;33(2): 7–13.
- Zheng Y, Ma S, Tan D, Lu M. A meta-analysis of liver lesions in hepatitis B patients undergoing antituberculosis therapy. Chinese Journal of Hepatology. 2014;22(8): 585–589.
- Suriawinata AA, Thung SN. Liver pathology. An Atlas and Concise Guide. New York: Demosmedical; 2011.
- Galimova SF. Medicinal lesions of the liver. Hepatology. 2012;(3): 38–48.
- Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, et al. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010. Epidemiology and Infection. 2015;143(9): 972–981.
- Feshchenko YuI, Todoriko LD, Kuzhko MM, Humenіuk MI. Tuberculosis pathomorphosis – the realities of today, chemoresistance as a sign of progression. Ukrainian Pulmonology Journal. 2018;(2): 6–10.
- Kaplowitz N, DeLeve LD. Drug-induced liver disease. New York: Informa Healthcare; 2007.
- Todoriko LD. Immunopathogenesis of drug-resistant tuberculosis from the standpoint of the present. Tuberculosis, Lung Diseases, HIV-Infection. 2017;30(3): 92–98.
- WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: World Health Organization; 2017. Available from:
https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf . - Cheng YJ, Li YL. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. Lung. 2014;192(1): 205–210.
- Zozulіak VI. Timely detection of signs of liver dysfunction in patients with destructive tuberculosis. Proceeding of the: XV Congress of the World Federation of Ukrainian Medical Associations. Kyiv – Chernivtsi; 2014, p. 54.
- Oprea C, Ianache I, Radoi R, Erscoiu S, Tardei G, Nicolaescu O, et al. Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users. Journal of International AIDS Society. 2014;17(4): 912–920.
- Men’shchikova EB, Lankin VZ, Zenkov NK. Oxidative stress. Pro-oxidants and anti-oxidants. Moscow: Slovo; 2006.
- Protsіuk RH. The problem of co-infection of tuberculosis, HIV-infection and viral hepatitis B and C in the world and Ukraine. Proceeding of the: XV Congress of the World Federation of Ukrainian Medical Associations. Kyiv – Chernivtsi; 2014. p. 48.